A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeysTANG, Roderick S; MAHMOOD, Kutubuddin; FOUCHIER, Ron A. M et al.Vaccine. 2005, Vol 23, Num 14, pp 1657-1667, issn 0264-410X, 11 p.Article

Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteinsHALLER, Aurelia A; LAUER, Georg M; DUKE, Richard C et al.Vaccine. 2007, Vol 25, Num 8, pp 1452-1463, issn 0264-410X, 12 p.Article

Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine designMACPHAIL, Mia; SCHICKLI, Jeanne H; TANG, Roderick S et al.Journal of general virology. 2004, Vol 85, pp 1655-1663, issn 0022-1317, 9 p., 6Article

Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 studyOSORIO, Jorge E; VELEZ, Ivan D; LUY, Betty E et al.Lancet. Infectious diseases (print). 2014, Vol 14, Num 9, pp 830-838, issn 1473-3099, 9 p.Article

Recovery of human metapneumovirus genetic lineages A and B from cloned cDNAHERFST, Sander; DE GRAAF, Miranda; FOUCHIER, Ron A. M et al.Journal of virology. 2004, Vol 78, Num 15, pp 8264-8270, issn 0022-538X, 7 p.Article